1. You may have problems with your prostate that aren’t cancer.

Childhood cancer survivors over age 50 had a threefold higher mortality risk compared with the general population, primarily ...

The use of clinical pathways in oncology care is increasingly important to patients and oncology providers as a tool for enhancing both quality and value. However, with increasing adoption of pathways ...

Sanjeev Luther, president and CEO of Ernexa Therapeutics reflects on how synthetic iMSCs could shift the approach to ovarian ...

Zon RT, Frame JN, Neuss MN, et al. American Society of Clinical Oncology policy statement on clinical pathways in oncology [published online January 12, 2016]. J Oncol Pract. pii: JOPR009134.

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the Stocks With Huge Catalysts on the Horizon. On June 2, UroGen Pharma Ltd. (NASDAQ:URGN) presented its uTRACT Registry study design at the 2025 American ...

The development and implementation of clinical cancer-practice guidelines that are relevant to varying levels of resources has been cited as a key element for improving cancer care in LMCs. 23 The ...

Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology ...

PRINCETON, N.J., May 22, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, today announced new ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...